NCT02825173View on ClinicalTrials.gov

Seal-G Safety Study

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

December 2, 2016

Conditions
Elective Surgical Procedures, Digestive System
Interventions
DEVICE

Seal-G

"Intervention:~Device: Seal-G Seal-G is applied adjunctively to cover standard closure techniques"

Trial Locations (3)

Unknown

Rabin Medical Center, Petah Tikva

Assaf Harofeh, Tzrifin

Humanitas Research Hospital, Rozzano Milano

All Listed Sponsors
lead

Sealantis Ltd.

INDUSTRY

NCT02825173 - Seal-G Safety Study | Biotech Hunter | Biotech Hunter